• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESHAPE MEDICAL INC. RESHAPE INTEGRATED DUAL BALLOON SYSTEM; INTRAGASTRIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESHAPE MEDICAL INC. RESHAPE INTEGRATED DUAL BALLOON SYSTEM; INTRAGASTRIC BALLOON Back to Search Results
Model Number 01-0011-001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Death (1802); Perforation (2001); Thrombus (2101)
Event Date 08/14/2017
Event Type  Death  
Event Description
Patient reported onset of back pain 3.5 weeks following balloon insertion.On (b)(6) 2017 md performed endoscopy, noted presence of significant amount of food in the stomach, removed the balloons and noted a distal gastric perforation.Perforation was surgically repaired and patient remained hospitalized for approximately 2 weeks for post-op management and treatment.On day of death (while still hospitalized), patient was ambulatory, non-febrile, with normal heart rate and white blood count but then experienced sudden heart rate drop and, despite immediate medical intervention efforts, expired on (b)(6) 2017.Icu md said cause of death was a pulmonary embolism by clinical presentation and no autopsy was done.
 
Manufacturer Narrative
Follow up #2 to correct patient code which was incorrectly coded as (b)(4) in follow up #1 and to add additional event information.
 
Event Description
Follow up: per the physician, one week after the balloon removal and perforation repair, the patient had a sudden onset of pain while still hospitalized and the white blood cell count was elevated.The patient was transferred to another hospital to obtain a cat scan and another gastric leak was found.The patient was taken to the or.It was determined the original repair was unsuccessful.The area was cleaned out, re-repaired and drained again.The patient continued to improve daily with a normal white cell count, afebrile, stable vitals and tolerating liquids.On day 7 following the second surgery, the patient had a sudden event and was transferred to icu where two hours of resusitation were unsuccessful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESHAPE INTEGRATED DUAL BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
RESHAPE MEDICAL INC.
100 calle iglesia
san clemente CA 92672 7502
Manufacturer (Section G)
RESHAPE MEDICAL INC.
100 calle iglesia
san clemente CA 92672 7502
Manufacturer Contact
lisa maloney
100 calle iglesia
san clemente, CA 92672-7502
9494296680
MDR Report Key6967005
MDR Text Key89912797
Report Number3007934906-2017-00032
Device Sequence Number1
Product Code LTI
UDI-Device IdentifierB001RSM1011
UDI-PublicB001RSM1011
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date05/09/2019
Device Model Number01-0011-001
Device Catalogue NumberRSM101
Device Lot Number170515-002
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age53 YR
-
-